Dec 20, 2007
R1507 Antibody to Enter Phase II Study to Treat Sarcoma
Dec 14, 2007
Genmab Announces Update on Ofatumumab Program
Dec 13, 2007
Grant of Warrants in GenmabA/S
Dec 13, 2007
Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
Dec 13, 2007
Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis
Dec 11, 2007
Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic
Dec 7, 2007
Genmab’s HuMax-CD38 Enters Phase I/II Clinical Trial for Multiple Myeloma
Dec 5, 2007
Genmab Wins Scrip’s Biotech Company of the Year Award
Nov 30, 2007
Genmab’s Total Number of Voting Rights and Total Share Capital
Nov 28, 2007
Genmab Announces Update on Recruitment of Patients in Ofatumumab CLL Pivotal Study
Nov 21, 2007
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Nov 20, 2007
Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
Nov 19, 2007
Genmab to Present at 19th Annual Piper Jaffray Health Care Conference
Nov 16, 2007
Genmab to Present HuMax-IL8 Pre-clinical Data
Nov 9, 2007
Genmab to Present Zanolimumab and Ofatumumab Data at ASH
Oct 30, 2007
Genmab Announces Results for the First Nine Months of 2007
Oct 23, 2007
Phase I Results Announced for R1507 from Genmab’s Collaboration with Roche
Oct 15, 2007
Genmab’s HuMax-CD4 Displays Unique Mechanism of Action
Oct 11, 2007
Genmab Amends HuMax-CD4 Pivotal Study in CTCL
Oct 4, 2007
Grant of Warrants in Genmab A/S
Oct 2, 2007
Roche Files CTA for Third Genmab Antibody
Oct 1, 2007
Major Shareholder Announcement
Oct 1, 2007
Genmab to Attend Two October Investor Conferences
Sep 28, 2007
Major Shareholder Announcement
Sep 28, 2007
Genmab’s Total Number of Voting Rights and Total Share Capital
Sep 27, 2007
Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study
Sep 18, 2007
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Sep 13, 2007
Genmab Provides Insights into IgG4 Antibodies
Sep 13, 2007
Genmab Discloses Target and Development Plans for HuMax-Inflam
Sep 13, 2007
Genmab Announces Asset Exchange Agreement
Sep 13, 2007
DAHANCA Initiates Head and Neck Cancer Study with Genmab’s HuMax-EGFr
Sep 7, 2007
Genmab Announces Encouraging Preclinical Data for Ofatumumab
Sep 3, 2007
Genmab to Attend Three September Investor Conferences
Aug 21, 2007
Genmab Announces 2007 First Half Year Results
Aug 10, 2007
Roche Files IND for Second Genmab Antibody
Aug 2, 2007
Genmab Regains Rights to HuMax-TAC
Jun 29, 2007
Genmab Announces Final HuMax-CD4 Phase II CTCL Data
Jun 29, 2007
Genmab Regains Rights to HuMax-CD4
Jun 29, 2007
Genmab’s Total Number of Voting Rights and Total Share Capital
Jun 27, 2007
Grant of Warrants to Board Members, Management and Employees in Genmab A/S
Jun 26, 2007
Genmab Reaches First Milestone in Ofatumumab Collaboration
Jun 18, 2007
Genmab Announces Development Plans for Ofatumumab
Jun 15, 2007
GlaxoSmithKline and Genmab Present Positive Phase II Results with Ofatumumab in Patients with Rheumatoid Arthritis (RA)
Jun 11, 2007
Genmab to Present at Two June Investor Conferences
Jun 3, 2007
Genmab’s HuMax-EGFr Shows Broad Potential in Cancer Treatment
Jun 1, 2007
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Jun 1, 2007
Genmab to Become Member of Copenhagen Stock Exchange’s OMXC20 Index
Jun 1, 2007
Genmab’s total number of voting rights and total share capital
May 21, 2007
Genmab’s HuMax-HepC Prevents Hepatitis C Virus Infection in Animal Model
May 14, 2007
Genmab Attends Two May Investor Conferences
May 8, 2007
Genmab Announces 2007 First Quarter Results
Apr 25, 2007
New Data on Genmab and GlaxoSmithKline’s Ofatumumab: Phase II Study in Rheumatoid Arthritis to be Presented at EULAR
Apr 24, 2007
Genmab to Present at 7th Annual Fortis Bank Biotechnology Conference
Apr 19, 2007
Constitution of the Board of Directors in Genmab and Grant of Warrants to Board Members and Employees
Apr 19, 2007
Passing of Genmab A/S’ Annual General Meeting
Apr 12, 2007
Genmab Initiates HuMax-EGFr Combination Study in Non Small Cell Lung Cancer
Mar 29, 2007
Genmab A/S Summons Annual General Meeting
Mar 19, 2007
Genmab to Present at Lehman Brothers Tenth Annual Global Healthcare Conference
Mar 16, 2007
Genmab in Research Cooperation with the DAHANCA-Group
Mar 12, 2007
New Insights into Novel Mechanisms of Action of Genmab’s HuMax-EGFr
Feb 22, 2007
Genmab to Present at Ninth Annual Bear Stearns London Healthcare Conference
Feb 14, 2007
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Feb 13, 2007
Genmab Announces Year End 2006 Financial Results
Feb 7, 2007
Capital Increase in Genmab as a Result of Execution of Private Placement to GlaxoSmithKline
Feb 5, 2007
Global Agreement for HuMax-CD20 Receives Antitrust Clearance
Feb 5, 2007
Genmab to Present at 2007 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
Jan 31, 2007
Genmab Announces Change in Board of Directors
Jan 2, 2007
Genmab's Financial Calendar for 2007